American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting is organized by American Society for Experimental Neurotherapeutics (ASENT) and will be held from Mar 12 - 14, 2024 at Hyatt Regency Bethesda, Bethesda, Maryland, United States of America.

Description:
ASENT's 2024 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centres gather to improve the process of bringing neurotherapeutics to market.

The Meeting features nine symposia, which address therapeutic advances in a broad range of neurologic disease states, processes and delivery methods; as well as interactive poster presentations, ASENT's celebrated pipeline presentations, and live discussion with speakers at the end of each day.

The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions focus on the latest science in neurotherapeutics. The conference content will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, satellite luncheons, networking meetings, pipeline presentations and poster sessions.

Why Attend ASENT 2024:
ASENT2024 is the premier neurotherapeutics conference where senior leaders through junior faculty and trainees from across payers, providers, employers, investors, fast-growing startups, industry, academia, policymakers, funders and innovation centres gather to ask one question: how can we improve the process of the development and discovery of neurotherapeutics?

Attendees are often surprised to find that more than 50% of participants are practicing physicians and the caliber of speakers is outstanding for a conference that provides ample opportunity to connect, network and converse. Additionally, the scientific content showcases the leading edge in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy, and the latest drug therapies and devices. The event features plenary sessions, fireside chats, panel discussions, business roundtables, and networking meetings.

Meeting Highlights: 

• FIRESIDE CHAT: Preclinical to First in Human in Neurotherapeutic Drug Development
• SYMPOSIA ON THE FOLLOWING:
• Platform Clinical Trials in Neurology
• Exosome in Neurotherapeutics
• Digital Biomarkers in CNS Clinical Studies
• Opportunities to streamline the development of gene therapies for rare diseases
• Current research and Advances in Multiple Sclerosis
• Parkinson's disease biological staging and implications for therapeutic trials
• Fluid Biomarkers as endpoints for neurodegenerative diseases
• Animal Models in Neurotherapeutics: the good, the bad and the ugly.
• Novel Delivery Systems in CNS
• LATEST DATA: Covid CNS Update
• DEBATE: Beta Amyloid Debate
• CNS PIPELINE Presentations
• CAREER DINNER Featuring Guest Speakers
• NEUROTHERAPEUTICS DINNER Featuring Guest Speakers
• Interactive Poster Discussions
• Live Discussions in Breakout Rooms with Speakers
• And much, much more!